Antibiotic resistance of 622 Streptococcus pneumoniae isolated from blood and cerebrospinal fluid in 33 Spanish hospitals participating in the European Antimicrobial Resistance Surveillance System (2000);Resistencia a antibióticos en 622 Streptococcus pneumoniae aislados de líquido cefalorraquídeo y sangre en 33 hospitales españoles de la Red Europea de Vigilancia de Resistencia a Antibióticos (2000)

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 1, 2003, Pages 12-19

  Oteo, Jesús ^a   Cruchaga, Susana ^a   Campos, José ^a   Sáez Nieto, Juan A ^a   Baquero, Fernando ^b   Hernandez J L ^c   Lite, J ^d   Garau, J ^d   Fontanals, D ^e   Segura, C ^f   Berdonces, P ^g   Del Valle Ortiz, O ^h   Wilhelmi, I ⁱ   Vasallo Vidal, F J ^j   Loza, E ^b   Pena P ^k   Gutierrez Altes A ^k   Garcia M ^l   Megias Lobon G ^m   Marti C ⁿ   Castanares M J ^o   Menendez Rivas M ^p   Bermudez P ^ae   Moreno, R ^ae   Buj, I ^q   Perez Moreno M M ^q   Elia M ^r   Merino, F ^ae   Perez Pomata M T ^ae   Tinajas, A ^s   Miranda, C ^t   Perez M D ^t   Fleites, A ^u   Amores, C ^v   Teno, P ^w   Carranza, R ^x   Gimeno, A ^y   Jimenez R ^y   Raya, C ^z   Soriano, F ^aa   Fernandez Roblas R ^aa   Fernandez B ^ab   Brezmes, M F ^ac   Cabezas, M T ^ad   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL DE CRUCES   (Spain)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

^e Hospital Universitari Parc Taulí   (Spain)

^f Laboratorio de Referencia de Catalunya   (Spain)

^g HOSPITAL DE GALDAKAO   (Spain)

^h HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

ⁱ HOSPITAL SEVERO OCHOA   (Spain)

^j HOSPITAL DO MEIXOEIRO   (Spain)

^k HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^l HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^m HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

ⁿ HOSPITAL GENERAL DE GRANOLLERS   (Spain)

^o HOSPITAL SAN PEDRO   (Spain)

^p HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^q Hospital Virgen de la Cinta   (Spain)

^r HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^s Department of Rheumatology   (Spain)

^t HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^u HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^v HOSPITAL SAN AGUSTÍN   (Spain)

^w HOSPITAL SAN PEDRO DE ALCÁNTARA   (Spain)

^x HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^y HOSPITAL INFANTA CRISTINA   (Spain)

^z HOSPITAL EL BIERZO   (Spain)

^aa Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^ab Hospital Santa Maria Nai   (Spain)

^ac HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^ad HOSPITAL DE PONIENTE   (Spain)

^ae Hospital de Poniente ^*

more..

Author keywords

Antibiotics; European Antimicrobial Resistance Surveillance System (EARSS); Streptococcus pneumoniae

Indexed keywords

CEFOTAXIME; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; HEALTH SURVEY; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATIENT INFORMATION; PENICILLIN RESISTANCE; QUALITY CONTROL; SPAIN; STRAIN IDENTIFICATION; STREPTOCOCCUS PNEUMONIAE; VALIDATION PROCESS;

EID: 12244267964     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13042132     Document Type: Article

References (19)

1. Williams RJ, Heymann DL. Containment of antimicrobial resistance. Science 1998;279:1153-4.
2. Thamdrup V, Borge K. Editores. The Microbial Threat. Recommendations of Europea Union Conference on The Microbial Threat; 1998, Septiembre 9-10; Copenhague. Denmark; Ministry of Health and Ministry of Food, Agriculture and Fisheries.
3. Baquero F, García-Rodríguez JA, García de Lomas JC, Aguilar L, and The Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study. Antimicrob Agents Chemother 1999;43:357-9.
4. Song JH, Lee NY, Ichiyama S, Yoshida R, Hirakata Y, Fu W, et al. Spread of drug-resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP) study. Clin Infect Dis 1999;28:1206-11.
5. Thornsberry C, Jones ME, Hickey ML, Mauriz Y, Kahn J, Sahm DF. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in the United States, 1997-1998. J Antimicrob Chemother 1999;44:749-59.
6. Pallarés R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, et al Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
7. Oteo J, Alos JI, Gómez-Garcés JL. Antimicrobial resistance of Streptococcus pneumoniae in 1999-2000 in Madrid (Spain): Multicenter surveillance study. J Antimicrob Chemother 2001;47:215-8.
8. Goosens H, Sprenger MJW. Community acquired infections and bacterial resistance. BMJ 1998;317:654-7.
9. Center for Disease Control. Guidelines for evaluating surveillance systems. MMWR 1988;37:S5.
10. Pérez-Trallero E, Fernández-Mazarrasa C, García-Rey C, Bouza E, Aguilar L, García de Lomas J, Baquero F, and The Spanish Surveillance Group for Respiratory Pathogens. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results ofd a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother 2001;45:3334-40.
11. Brueggemann AB, Pfaller MA, Doern GV. Use of penicillin MICs to predict the activity of other β-lactam antimicrobial agents against Streptococcus pneumoniae. J Clin Microbiol 2001;39:367-9.
12. Schmitz FJ, Verhoef J, Fluit AC, and the SENTRY participants group. Comparative activity of 27 antimicrobial compounds against 698 Streptococcus pneumoniae isolates originating from 20 European University Hospitals. Eur J Clin Microbiol Infect Dis 1999;18:450-3.
13. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother 2001;45:1721-9.
14. Doern GV, Pfaller MA, Kugler K, Freeman J, Jones RN. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY Antimicrobial Surveillance Program. Clin Infect Dis 1998;27:764-70.
15. Marco F, Bouza E, García de Lomas J, Aguilar L, and the Spanish Surveillance Group for Respiratory Pathogens. Streptococcus pneumoniae in community-acquired respiratory tract infection in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. J Antimicrob Chemother 2000; 46:557-64.
16. Novak R, Henriques B, Charpentier E, Normark S, Tuomanen E. Emergence of vancomycin tolerance in Streptococcus pneumoniae. Nature 1999;339:590-3.
17. Chen DK, McGeer A, De Azvedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluorquinolones in Canada. N Engl J Med 1999;341:233-9.
18. Liñares J, De la Campa AG, Pallarés R. Fluorquinolone resistance in Streptococcus pneumoniae. N Engl J Med 1999;341:1546-7.
19. García-Rey C, Aguilar L, Baquero F, Spanish Surveillance Group for Respiratory Pathogens. Influences of different factors on prevalence of ciprofloxacin resistance in Streptococcus pneumoniae in Spain. Antimicrob Agents Chemother 2000;44:3481-2.